Akumin Inc. (TSX-V: AKU) is a leading provider of free-standing, fixed-site outpatient diagnostic imaging services in the United States with a network of 71 owned and/or operated imaging centres located in Florida, Pennsylvania, Delaware, Texas, Illinois and Kansas. By combining its clinical expertise with the latest advances in technology and information systems, the company’s centres provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. PowerOne was an early shareholder and works closely with management. PowerOne has also acted as finder for a US$3.5 million non-brokered financing in August 2015 and a US$5.6 million non-brokered financing in May 2016. PowerOne acted as co-lead agent for a US$10.5 million financing in March of 2017 and co-lead agent for a US$34.8 million financing in August of 2017.
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive and interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; and sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and pain management device, such as SiLo, a posterior fusion device for the sacroiliac joint. The company was incorporated in 2013 and is headquartered in Toronto, Canada.
Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogot Savannah of central Colombia and operations currently being established in Argentina. Led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis. Blueberries? combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
Alegro Health Corp. (TSX-V: AGO), a provider of medical, surgical and rehabilitation and disability management services.
Antisense Therapeutics is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Canabo wholly owns and operates Cannabinoid Medical Clinics, or CMClinics, Canada’s largest physician led referral-only clinics for medical cannabis. Established in 2014, Canabo now has 22 clinics across Canada, with additional locations planned to open in 2018. Canabo operates referral-only medical clinics dedicated to evaluating the suitability of prescribing, and monitoring cannabinoid treatments for patients suffering from chronic pain and disabling illnesses. Clinics operated by Canabo are staffed by physicians and qualified health care practitioners specifically trained to assess patient suitability for cannabinoid treatment, recommend treatment regimes, and monitor treatment progress.
Landdrill International, Inc. offers drilling services to the mineral exploration and mining industries. The Company operates primarily in Mongolia.
Sante Veritas Therapeutics Inc. (CSE: SV) is striving to be one of Canada?s premier producer of pharma-grade, innovative, market-informed, cannabis products developed through state of the art genetics and grow environments, balancing market responsiveness with efficient production capabilities. PowerOne was finder and early investor in the company?s $7.7M financing in February 2017 and Co-Agent in the company?s $16M financing in December 2017. Sante Veritas has also announced a merger with Baker Technologies Inc., Briteside Holdings LLC, and Sea Hunter to form Tilt Holdings Inc., expanding into the United States and forming one of the most comprehensive industry platforms.
TILT Holdings Inc. (?TILT? or the ?Company?), which is a vertically-integrated technology and infrastructure platform delivering a comprehensive range of products and services across the cannabis industry.
True Health, also known as Sante Veritas Therapeutics, applied to the federal government and began the process to become a licensed producer for its marijuana for medical purposes regulations program.
Xanthic, through its wholly-owned operating subsidiary, Xanthic Biopharma Limited, provides valuable intellectual property to cannabis industry participants, enabling its strategic partners to produce high quality, innovative, non-combustible cannabis, and cannabis-infused products which deliver consistent THC and/or CBD levels and improved bioavailability. Using a patent-pending proprietary process, Xanthic allows its strategic partners to deliver superior cannabinoid solubility, improved bioavailability, accurate micro-dosing and greater consistency versus competitive infused products. Through its investment in Xanthic Beverages, Xanthic has access to non-cannabis derived CBD-infused products that qualify for distribution outside of the cannabis dispensary network and into mainstream retail. www.xanthicbio.com